Today on The Tape Reader: The AI momentum unwind is turning into a full-blown historic rout across Asian semiconductor markets, violently invalidating yesterday's oversold signals. As capital flees the chip sector, we're seeing an immediate rotation into software and Indian IT. We're also tracking a contrarian call for a Fed rate hike tomorrow from Citadel Securities, adding to the mounting macro tension.
The momentum unwind we've been tracking in the semiconductor sector has accelerated violently, invalidating yesterday's technical oversold signals. A historic sell-off slammed Asian semiconductor stocks on Tuesday, with South Korea's KOSPI plunging nearly 11% and Japan's Nikkei 225 falling almost 4%. The rout was led by double-digit declines in memory giants Samsung and SK Hynix, as well as Kioxia. The contagion is spreading to US markets, where Nasdaq futures are down sharply, driven by concerns over intensifying Chinese competition, reports of China's homegrown DUV lithography progress, and investor skepticism about the circular financing of AI capital expenditures. SanDisk (SNDK) is down over 5% in pre-market trading.
Why it matters
This isn't just profit-taking; it's a structural challenge to the semiconductor thesis, aligning with Goldman Sachs' recent warnings about the leveraged momentum unwind. The combination of credible Chinese competition and scrutiny of AI capex models is forcing a fundamental re-rating of the sector. For traders, this accelerates the rotation theme, creates widespread weakness for potential short setups, and raises the stakes for upcoming earnings from US tech giants who are the ultimate customers of these chips.
AI infrastructure supplier Celestica (CLS) reported a massive Q2 earnings beat and raised its guidance, sending the stock up 9% in after-hours trading on Monday. The company posted revenue of $4.70 billion (up 62% YoY) and adjusted EPS of $2.54, crushing estimates of $4.39 billion and $2.30. Crucially, Celestica raised its 2026 revenue forecast to $20.5 billion and adjusted EPS to $11.30, and projected that revenue growth would accelerate beyond 65% in 2027.
Why it matters
This is a powerful episodic pivot. While AI 'consumers' like Google face scrutiny over capex, suppliers like Celestica are demonstrating immense operating leverage. The blowout numbers and, more importantly, the multi-year guidance acceleration, validate the 'picks and shovels' thesis and set the stock up for a potential major breakout. It provides a key positive read-through for other hardware suppliers.
T1 Energy (TE) pre-announced disappointing Q2 results, projecting a net loss from continuing operations of $34-$37 million. In a double blow, the company also jacked up its capital expenditure guidance for its G2_Austin Phase 1 project by nearly 20% to $510 million and delayed the start of first-cell production to Q1 2027. The stock fell over 7% on the news.
Why it matters
This is a trifecta of bad news that sets up a classic earnings gapper to the downside. Cost overruns, project delays, and a wider-than-expected loss create a negative fundamental story that often leads to institutional selling. This provides a clear short candidate, as the market reprices the company's execution risk and future cash flows.
TransUnion (TRU) reported Q2 adjusted EPS of $1.23 on revenue of $1.31 billion, handily beating analyst estimates for $1.15 and $1.28 billion, respectively. The credit reporting agency also raised its full-year guidance, now expecting revenue of $5.13B-$5.16B and adjusted EPS of $4.75-$4.83. The stock is reacting positively to the news in pre-market trading.
Why it matters
A clean beat-and-raise from a financial data company like TransUnion provides a positive signal about the health of the consumer and lending markets. For traders, this creates an episodic pivot setup, where strong fundamental news acts as a catalyst for a potential breakout and upward trend continuation.
Shares of Capricor Therapeutics (CAPR) collapsed by more than 67% on Monday after the FDA released devastating briefing documents ahead of a July 29 advisory committee meeting. FDA staff reviewers raised significant doubts about the efficacy and safety of the company's Duchenne muscular dystrophy (DMD) therapy, deramiocel. The agency stated the Phase 3 trial failed its primary endpoint, questioned post-hoc changes to the statistical analysis, and concluded the data may not meet the standard for substantial evidence of effectiveness.
Why it matters
This is a clinical-stage biotech nightmare and a classic catalyst-driven implosion. The FDA's critique is so thorough that it makes a positive AdCom vote seem highly improbable, effectively putting the viability of Capricor's lead asset in severe jeopardy. The stock has become a trading vehicle on any potential for a dead-cat bounce versus continued downside pressure into the now-critical AdCom meeting on Wednesday.
Wall Street analysts delivered a major shakeup in the auto sector on Monday, adding to the bullish momentum we've seen in General Motors. Jefferies upgraded both GM to 'Buy' with a $99 price target and Ford (F) to 'Buy' with a $17.50 target, citing strong free cash flow prospects. In a sharply contrasting call, Piper Sandler double-downgraded Stellantis (STLA) to 'Sell' and slashed its price target to just $4, citing competitive pressures. Separately, Piper also upgraded EV maker Rivian (RIVN) to 'Overweight'.
Why it matters
This is a clear, actionable divergence call from major desks. The upgrades for GM and Ford provide a bullish catalyst for the US legacy automakers, while the brutal downgrade for Stellantis creates a compelling short setup. These conflicting ratings signal a definitive preference for certain names within the sector and are likely to drive performance dispersion and rotational flows.
After a sharp sell-off, the Nasdaq 100 Index (NDX) is showing multiple technical and positioning signals that suggest a potential for a short-term rebound. Analysis points to oversold conditions, cleared-out hedge fund positioning, elevated demand for downside protection, and extreme relative weakness in hyperscalers. A modified Guppy chart analysis for QQQ also notes the index is 'very oversold' with its Super Fast Stochastic indicator below 10, suggesting a bounce may be imminent.
Why it matters
The confluence of deeply oversold technical indicators and washed-out positioning creates a classic mean reversion setup. The current environment is primed for a tactical short squeeze, where even a small positive catalyst could force shorts to cover and trigger a sharp upward move. This offers a compelling risk-reward for a tactical long position in QQQ or related tech names.
The mean reversion setup we've been tracking in Micron (MU) has intensified, with the stock's ongoing 30% washout now pushing its forward P/E ratio down to a notably low 6.3. Despite the sharp correction, concerns about Chinese competition, and recent short-selling pressure from Michael Burry, analysis suggests the company's underlying fundamentals have not significantly deteriorated since its highs in June. The stock remains a key battleground between momentum short-sellers and value-seeking buyers.
Why it matters
The dramatic sell-off in a sector leader like Micron, compressing its valuation to single digits despite no major change in its own fundamentals, presents a potential asymmetric risk/reward setup. This is a classic 'washed-out leader' scenario. Traders will be watching to see if the stock can find support and reverse, distinguishing an emotional overshoot from the start of a longer-term downturn.
The 38% probability of a surprise quarter-point Federal Reserve rate hike at Wednesday's meeting that we highlighted yesterday is gaining institutional traction, according to macro researcher Jim Bianco. While most economists expect a hold, Citadel Securities has made a contrarian call for a hike to end forward guidance. The rising odds reflect persistent inflation concerns, driven by energy prices, which have created a significant divergence between market pricing and consensus expectations.
Why it matters
A 38% chance is far from a trivial probability and indicates the market is seriously contemplating a hawkish surprise that could trigger significant volatility. A hike would likely strengthen the dollar, hit risk assets hard, and force a major repricing across markets. The key tactical consideration is that a large portion of the market is not positioned for this outcome, setting the stage for an explosive move if Citadel's call proves correct.
The institutional rotation out of semiconductors that we've been tracking is finding new beneficiaries: previously unloved software stocks and Indian IT services giants. On Monday, shares of Salesforce, ServiceNow, and Workday surged as investors moved out of chipmakers. The trend accelerated Tuesday as Indian IT stocks like TCS, Infosys, and Coforge rallied up to 10%. The move was amplified by a major call from Jefferies, which upgraded the Indian IT sector to 'Neutral' from 'Underweight', citing the fading global AI trade as a catalyst for foreign investors to return to India.
Why it matters
This is the most decisive sector rotation in weeks. The narrative is shifting from underwriting the 'picks and shovels' of AI (chips) to favoring the profitable application layer (software) and outsourced services (Indian IT). This presents a clear thematic trade, with momentum building in names like INFY and software ETFs, while offering potential fade opportunities in the most extended semiconductor names.
Cadence Design Systems (CDNS) raised its full-year 2026 guidance after reporting a strong Q2 earnings beat on Monday. The electronic design automation firm now sees higher revenue and profit for the year, citing broad-based demand, particularly strong AI-related activity, and a record backlog of $8.1 billion. Shares rose in after-hours trading on the news.
Why it matters
Cadence provides the essential tools for chip design, making it a crucial upstream player in the AI ecosystem. Unlike the chipmakers themselves who face manufacturing and competition risks, CDNS benefits from the sheer volume of design activity. This beat-and-raise, driven by a record backlog, signals sustained, high-margin demand and provides another clear episodic pivot catalyst in the semiconductor supply chain.
Shares of T3 Defense Inc. (DFNS) have been on a parabolic run, surging another 58% on Monday. The move appears to be driven by low-float dynamics following a 1-for-125 reverse stock split on July 20th. The stock has exploded from under $0.20 to the $6-$7 range this month, catalyzed by a recent multi-billion dollar defense contract announcement, and is exhibiting extreme intraday volatility.
Why it matters
DFNS is a textbook example of a low-float parabolic runner, where a reverse split dramatically reduced the number of available shares, making the stock highly susceptible to explosive moves on news. While institutional holders like UBS and BlackRock were on file pre-split, the current action is likely driven by retail momentum. This creates a high-velocity, high-risk trading environment for both long continuation and eventual blow-off top short setups.
Semiconductor Rout Intensifies on China and Financing Fears A massive sell-off in Asian memory chipmakers is spreading to the US pre-market, fueled by reports of China's homegrown lithography advancements and growing skepticism about AI financing schemes. The rout is pressuring the entire semiconductor ecosystem and has seen Apple reclaim its market cap lead over Nvidia.
Rotation Out of Chips Fuels Software and Indian IT Rally Capital is decisively rotating out of the battered semiconductor sector and into previously beaten-down software names like Salesforce and ServiceNow, as well as Indian IT giants. A Jefferies upgrade of the Indian IT sector, citing the fading global AI trade, has amplified the move.
FDA Catalyst Wrecks Capricor, Highlights Biotech's Binary Risk Capricor Therapeutics plunged nearly 70% after FDA briefing documents ahead of its AdCom meeting eviscerated the data for its lead Duchenne therapy. The event is a stark reminder of the make-or-break nature of regulatory catalysts in the biotech space.
Earnings Beats and Guidance Raises Drive Episodic Pivots Despite broader market anxiety, several companies are reporting strong earnings and raising guidance, creating classic episodic pivot setups. Celestica and Cadence Design Systems are gapping up on AI-driven demand, while TransUnion is also rising on a beat-and-raise report.
July Fed Hike Odds Creep Higher Ahead of Decision While a hold is still the base case, the market-implied odds of a surprise Fed rate hike this week have climbed to around 30-38%, according to various prediction markets and futures pricing. The uncertainty is adding another layer of tension ahead of tomorrow's announcement.
What to Expect
2026-07-29—FOMC interest rate decision and press conference.
2026-07-29—FDA Advisory Committee meeting for Capricor Therapeutics (CAPR).
2026-07-29—Earnings reports from Meta Platforms (META) and Boeing (BA).
2026-07-30—Earnings reports from Apple (AAPL) and Amazon (AMZN).
2026-08-03—Palantir (PLTR) scheduled to report Q2 earnings.
How We Built This Briefing
Every story, researched.
Every story verified across multiple sources before publication.
🔍
Scanned
Across multiple search engines and news databases
645
📖
Read in full
Every article opened, read, and evaluated
210
⭐
Published today
Ranked by importance and verified across sources
12
— The Tape Reader
🎙 Listen as a podcast
Subscribe in your favorite podcast app to get each new briefing delivered automatically as audio.
Apple Podcasts
Library tab → ••• menu → Follow a Show by URL → paste